| Literature DB >> 27198960 |
Patrick J Goleski1, Mark Reisman1, Creighton W Don1.
Abstract
Thrombotic aortic valve restenosis following transcatheter aortic valve replacement (TAVR) has not been extensively reported and the rates of TAVR valve thrombosis are not known. We present three cases of valve-in-valve (VIV) restenosis following TAVR with the balloon expandable transcatheter heart valves, presumably due to valve thrombosis that improved with anticoagulation.Entities:
Keywords: anticoagulants/antithrombins; antiplatelet therapy; aortic valve disease; percutaneous intervention; percutaneous valve therapy; structural heart disease intervention; transcatheter valve implantation
Mesh：
Substances：
Year: 2016 PMID： 27198960 DOI： 10.1002/ccd.26522
Source DB: PubMed Journal: Catheter Cardiovasc Interv ISSN： 1522-1946 Impact factor: 2.692